Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
66.4M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
+$49.8M
-
Put/Call ratio
-
0.14
-
Number of buys
-
112
-
Number of sells
-
-102
-
Price
-
$24.81
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2016
252 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2016.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.4M shares
of 115M outstanding shares and own 57.63% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.63M shares), VANGUARD GROUP INC (5.4M shares), BlackRock Fund Advisors (4.39M shares), JANUS CAPITAL MANAGEMENT LLC (3.26M shares), Bank of New York Mellon Corp (2.57M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (2.41M shares), STATE STREET CORP (2.17M shares), Van Berkom & Associates Inc. (2.15M shares), BlackRock Institutional Trust Company, N.A. (2.14M shares), and OAK RIDGE INVESTMENTS LLC (1.94M shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.